24,25-epoxycholesterol has been researched along with androst-16-en-3-one in 1 studies
Studies (24,25-epoxycholesterol) | Trials (24,25-epoxycholesterol) | Recent Studies (post-2010) (24,25-epoxycholesterol) | Studies (androst-16-en-3-one) | Trials (androst-16-en-3-one) | Recent Studies (post-2010) (androst-16-en-3-one) |
---|---|---|---|---|---|
65 | 0 | 18 | 155 | 1 | 68 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ai, N; Ekins, S; Hagey, LR; Krasowski, MD; Reschly, EJ; Welsh, WJ | 1 |
1 other study(ies) available for 24,25-epoxycholesterol and androst-16-en-3-one
Article | Year |
---|---|
Ligand specificity and evolution of liver X receptors.
Topics: Androstenes; Animals; Benzoates; Benzylamines; Carbazoles; Cell Line, Tumor; Cholesterol; Ciona intestinalis; DNA-Binding Proteins; Evolution, Molecular; Humans; Hydrocarbons, Fluorinated; Hydroxycholesterols; Liver X Receptors; Mice; Molecular Structure; Orphan Nuclear Receptors; Phylogeny; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Sulfonamides; Xenopus laevis; Zebrafish | 2008 |